squibb-cas career scientist award Search Results


bristolmyers squibbco  (Bristol Myers)
86
Bristol Myers bristolmyers squibbco
Bristolmyers Squibbco, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/squibb-cas+career+scientist+award/bristol+myers+squibbco/10__1158_slash_1078___0432__ccr___21___3194-201-5-5
Average 86 stars, based on 1 article reviews
bristolmyers squibbco - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
ca corynebacterium bovis cb  (Bristol Myers)
86
Bristol Myers ca corynebacterium bovis cb
Ca Corynebacterium Bovis Cb, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/squibb-cas+career+scientist+award/bovis+ca+cb+corynebacterium/pmc10597326-6305-60-56
Average 86 stars, based on 1 article reviews
ca corynebacterium bovis cb - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
elotuzumab  (Bristol Myers)
86
Bristol Myers elotuzumab
Elotuzumab, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/squibb-cas+career+scientist+award/elotuzumab/pm41892363-205-8-12
Average 86 stars, based on 1 article reviews
elotuzumab - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
urelumab  (Bristol Myers)
86
Bristol Myers urelumab
Urelumab, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/squibb-cas+career+scientist+award/urelumab/us12459895-1081-12-14
Average 86 stars, based on 1 article reviews
urelumab - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
fdc atripla  (Bristol Myers)
86
Bristol Myers fdc atripla
Fdc Atripla, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/squibb-cas+career+scientist+award/atripla+fdc/10__1097_slash_qai__0b013e31820dc1c8-86-5-7
Average 86 stars, based on 1 article reviews
fdc atripla - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
car t therapies  (Bristol Myers)
86
Bristol Myers car t therapies
Distribution of clinical trials by cell therapy type across major regions. This grouped bar chart compares the absolute number of registered clinical trials for different categories of cell therapy <t>(e.g.,</t> <t>CAR-T,</t> TCR-T, stem cells, etc.) conducted globally and within the United States, China, and the European Union. The data scope and time period (1999 – October 2025) are identical to those in . For each cell therapy type on the x-axis, the grouped bars (from left to right within each cluster) represent the trial counts for the Global total, United States, China, and European Union, respectively. The color scheme is consistent with : yellow (Global), blue (United States), red (China), and green (European Union). Data were aggregated from the same three registries ( ClinicalTrials.gov , ChiCTR, EU-CTR).
Car T Therapies, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/squibb-cas+career+scientist+award/car+t+therapies/pmc12926371-194-7-2
Average 86 stars, based on 1 article reviews
car t therapies - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
emtricitabin str tee  (Gilead Sciences)
99
Gilead Sciences emtricitabin str tee
Distribution of clinical trials by cell therapy type across major regions. This grouped bar chart compares the absolute number of registered clinical trials for different categories of cell therapy <t>(e.g.,</t> <t>CAR-T,</t> TCR-T, stem cells, etc.) conducted globally and within the United States, China, and the European Union. The data scope and time period (1999 – October 2025) are identical to those in . For each cell therapy type on the x-axis, the grouped bars (from left to right within each cluster) represent the trial counts for the Global total, United States, China, and European Union, respectively. The color scheme is consistent with : yellow (Global), blue (United States), red (China), and green (European Union). Data were aggregated from the same three registries ( ClinicalTrials.gov , ChiCTR, EU-CTR).
Emtricitabin Str Tee, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/squibb-cas+career+scientist+award/Atripla/10__1097_slash_qai__0000000000000199-18-23-25
Average 99 stars, based on 1 article reviews
emtricitabin str tee - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
nivolumab  (Bristol Myers)
86
Bristol Myers nivolumab
Distribution of clinical trials by cell therapy type across major regions. This grouped bar chart compares the absolute number of registered clinical trials for different categories of cell therapy <t>(e.g.,</t> <t>CAR-T,</t> TCR-T, stem cells, etc.) conducted globally and within the United States, China, and the European Union. The data scope and time period (1999 – October 2025) are identical to those in . For each cell therapy type on the x-axis, the grouped bars (from left to right within each cluster) represent the trial counts for the Global total, United States, China, and European Union, respectively. The color scheme is consistent with : yellow (Global), blue (United States), red (China), and green (European Union). Data were aggregated from the same three registries ( ClinicalTrials.gov , ChiCTR, EU-CTR).
Nivolumab, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/squibb-cas+career+scientist+award/nivolumab/us12404497-421-22-24
Average 86 stars, based on 1 article reviews
nivolumab - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
mitomycin c  (Kirin Co Ltd)
86
Kirin Co Ltd mitomycin c
Distribution of clinical trials by cell therapy type across major regions. This grouped bar chart compares the absolute number of registered clinical trials for different categories of cell therapy <t>(e.g.,</t> <t>CAR-T,</t> TCR-T, stem cells, etc.) conducted globally and within the United States, China, and the European Union. The data scope and time period (1999 – October 2025) are identical to those in . For each cell therapy type on the x-axis, the grouped bars (from left to right within each cluster) represent the trial counts for the Global total, United States, China, and European Union, respectively. The color scheme is consistent with : yellow (Global), blue (United States), red (China), and green (European Union). Data were aggregated from the same three registries ( ClinicalTrials.gov , ChiCTR, EU-CTR).
Mitomycin C, supplied by Kirin Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/squibb-cas+career+scientist+award/c+mitomycin/10__1590_slash_s0001___37652013000200008-30-0-13
Average 86 stars, based on 1 article reviews
mitomycin c - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
chimeric antigen receptor car t cell therapy  (Bristol Myers)
86
Bristol Myers chimeric antigen receptor car t cell therapy
Distribution of clinical trials by cell therapy type across major regions. This grouped bar chart compares the absolute number of registered clinical trials for different categories of cell therapy <t>(e.g.,</t> <t>CAR-T,</t> TCR-T, stem cells, etc.) conducted globally and within the United States, China, and the European Union. The data scope and time period (1999 – October 2025) are identical to those in . For each cell therapy type on the x-axis, the grouped bars (from left to right within each cluster) represent the trial counts for the Global total, United States, China, and European Union, respectively. The color scheme is consistent with : yellow (Global), blue (United States), red (China), and green (European Union). Data were aggregated from the same three registries ( ClinicalTrials.gov , ChiCTR, EU-CTR).
Chimeric Antigen Receptor Car T Cell Therapy, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/squibb-cas+career+scientist+award/cell+therapy/pm33951381-118-6-0
Average 86 stars, based on 1 article reviews
chimeric antigen receptor car t cell therapy - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
sns-032  (Sunesis Inc)
90
Sunesis Inc sns-032
Distribution of clinical trials by cell therapy type across major regions. This grouped bar chart compares the absolute number of registered clinical trials for different categories of cell therapy <t>(e.g.,</t> <t>CAR-T,</t> TCR-T, stem cells, etc.) conducted globally and within the United States, China, and the European Union. The data scope and time period (1999 – October 2025) are identical to those in . For each cell therapy type on the x-axis, the grouped bars (from left to right within each cluster) represent the trial counts for the Global total, United States, China, and European Union, respectively. The color scheme is consistent with : yellow (Global), blue (United States), red (China), and green (European Union). Data were aggregated from the same three registries ( ClinicalTrials.gov , ChiCTR, EU-CTR).
Sns 032, supplied by Sunesis Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/squibb-cas+career+scientist+award/sns+032/pmc04039040-212-0-2
Average 90 stars, based on 1 article reviews
sns-032 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
combination with paclitaxel  (Bristol Myers)
86
Bristol Myers combination with paclitaxel
Distribution of clinical trials by cell therapy type across major regions. This grouped bar chart compares the absolute number of registered clinical trials for different categories of cell therapy <t>(e.g.,</t> <t>CAR-T,</t> TCR-T, stem cells, etc.) conducted globally and within the United States, China, and the European Union. The data scope and time period (1999 – October 2025) are identical to those in . For each cell therapy type on the x-axis, the grouped bars (from left to right within each cluster) represent the trial counts for the Global total, United States, China, and European Union, respectively. The color scheme is consistent with : yellow (Global), blue (United States), red (China), and green (European Union). Data were aggregated from the same three registries ( ClinicalTrials.gov , ChiCTR, EU-CTR).
Combination With Paclitaxel, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/squibb-cas+career+scientist+award/paclitaxel+%E2%80%A2/us12551490-1234-8-15
Average 86 stars, based on 1 article reviews
combination with paclitaxel - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results


Distribution of clinical trials by cell therapy type across major regions. This grouped bar chart compares the absolute number of registered clinical trials for different categories of cell therapy (e.g., CAR-T, TCR-T, stem cells, etc.) conducted globally and within the United States, China, and the European Union. The data scope and time period (1999 – October 2025) are identical to those in . For each cell therapy type on the x-axis, the grouped bars (from left to right within each cluster) represent the trial counts for the Global total, United States, China, and European Union, respectively. The color scheme is consistent with : yellow (Global), blue (United States), red (China), and green (European Union). Data were aggregated from the same three registries ( ClinicalTrials.gov , ChiCTR, EU-CTR).

Journal: Frontiers in Pharmacology

Article Title: Global Panoramic analysis of clinical research in cell therapy: clinical trial landscape, marketed products, and regulatory trends

doi: 10.3389/fphar.2026.1715984

Figure Lengend Snippet: Distribution of clinical trials by cell therapy type across major regions. This grouped bar chart compares the absolute number of registered clinical trials for different categories of cell therapy (e.g., CAR-T, TCR-T, stem cells, etc.) conducted globally and within the United States, China, and the European Union. The data scope and time period (1999 – October 2025) are identical to those in . For each cell therapy type on the x-axis, the grouped bars (from left to right within each cluster) represent the trial counts for the Global total, United States, China, and European Union, respectively. The color scheme is consistent with : yellow (Global), blue (United States), red (China), and green (European Union). Data were aggregated from the same three registries ( ClinicalTrials.gov , ChiCTR, EU-CTR).

Article Snippet: In 2021, Bristol Myers Squibb launched two CAR-T therapies: Lisocabtagene maraleucel (brand name Breyanzi®) and Idecabtagene vicleucel (brand name Abecma®).

Techniques: Clinical Proteomics